Abstract
References
Articles referenced by this article (43)
A Review of Mesoporous Silica Nanoparticle Delivery Systems in Chemo-Based Combination Cancer Therapies.
Front Chem, 598722 2020
MED: 33330389
Current Status of Therapeutic Drug Monitoring of 5-Fluorouracil Prodrugs.
Anticancer Res, (8):4655-4661 2020
MED: 32727789
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer.
ACS Nano, (1):38-53 2018
MED: 30525443
Fast solid-phase extraction of N-linked glycopeptides by amine-functionalized mesoporous silica nanoparticles.
Analyst, (8):2435-2440 2016
MED: 27001691
pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Colloids Surf B Biointerfaces, 287-296 2017
MED: 28351801
Lectin-functionalized mesoporous silica nanoparticles for endoscopic detection of premalignant colonic lesions.
Nanomedicine, (6):1941-1952 2017
MED: 28363770
Multifunctional biomolecule nanostructures for cancer therapy.
Nat Rev Mater, (9):766-783 2021
MED: 34026278
Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Carbohydr Polym, 117893 2021
MED: 33766378
Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon.
ACS Appl Mater Interfaces, (11):9470-9483 2017
MED: 28252278
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy.
Int J Nanomedicine, 1241-1256 2018
MED: 29535520
Show 10 more references (10 of 43)
Citations & impact
Impact metrics
Article citations
Anti-cancer Drug Targeting using Stimuli Sensitive Mesoporous Silica Nanoparticle in Colorectal Cancer.
Curr Pharm Des, 30(39):3071-3073, 01 Jan 2024
Cited by: 0 articles | PMID: 39234908
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Biosafety of mesoporous silica nanoparticles; towards clinical translation.
Adv Drug Deliv Rev, 201:115049, 12 Aug 2023
Cited by: 13 articles | PMID: 37573951
Review
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy.
Int J Nanomedicine, 13:1241-1256, 01 Mar 2018
Cited by: 48 articles | PMID: 29535520 | PMCID: PMC5841950
Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment.
Pharmaceutics, 15(10):2483, 17 Oct 2023
Cited by: 0 articles | PMID: 37896243 | PMCID: PMC10609930
Review Free full text in Europe PMC
A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Recent Pat Drug Deliv Formul, 14(2):126-144, 01 Jan 2020
Cited by: 3 articles | PMID: 32928094
Review